3 Reasons to Sell APOG and 1 Stock to Buy Instead

APOG Cover Image

Since August 2025, Apogee has been in a holding pattern, posting a small loss of 4% while floating around $40.96. The stock also fell short of the S&P 500’s 7.6% gain during that period.

Is there a buying opportunity in Apogee, or does it present a risk to your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free.

Why Do We Think Apogee Will Underperform?

We don't have much confidence in Apogee. Here are three reasons you should be careful with APOG and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term sales performance is one signal of its overall quality. Any business can have short-term success, but a top-tier one grows for years. Regrettably, Apogee’s sales grew at a sluggish 2.1% compounded annual growth rate over the last five years. This fell short of our benchmarks.

Apogee Quarterly Revenue

2. Revenue Projections Show Stormy Skies Ahead

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Apogee’s revenue to drop by 1.8%, a decrease from its 2.1% annualized growth for the past five years. This projection doesn't excite us and suggests its products and services will face some demand challenges.

3. EPS Took a Dip Over the Last Two Years

Although long-term earnings trends give us the big picture, we like to analyze EPS over a shorter period to see if we are missing a change in the business.

Sadly for Apogee, its EPS declined by 12.4% annually over the last two years while its revenue was flat. This tells us the company struggled to adjust to choppy demand.

Apogee Trailing 12-Month EPS (Non-GAAP)

Final Judgment

We see the value of companies helping their customers, but in the case of Apogee, we’re out. With its shares underperforming the market lately, the stock trades at 13.3× forward P/E (or $40.96 per share). This valuation is reasonable, but the company’s shaky fundamentals present too much downside risk. There are better stocks to buy right now. We’d recommend looking at one of our top digital advertising picks.

Stocks We Like More Than Apogee

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.11
+5.25 (2.56%)
AAPL  264.58
+4.00 (1.54%)
AMD  200.15
-3.22 (-1.58%)
BAC  53.06
+0.29 (0.55%)
GOOG  314.90
+11.34 (3.74%)
META  655.66
+10.88 (1.69%)
MSFT  397.23
-1.23 (-0.31%)
NVDA  189.82
+1.92 (1.02%)
ORCL  148.08
-8.46 (-5.40%)
TSLA  411.82
+0.11 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.